{"id":"sl-2003-24","name":"Supervised Injecting Place Trial Regulation 2003","slug":"supervised-injecting-place-trial-regulation-2003","collection":"regulation","jurisdiction":"act","status":"in_force","isInForce":true,"actNumber":"24 of 2003","makingDate":null,"administeringDepartment":null,"currentVersion":{"id":173834,"registerId":"act-sl-2003-24-current","compilationNumber":null,"startDate":"2026-04-05","status":"InForce","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Supervised Injecting Place Trial Regulation 2003","content":"Australian Capital Territory\nSupervised Injecting Place Trial\nRegulation 2003\nSL2003-24\nmade under the\nSupervised Injecting Place Trial Act 1999\nRepublication No 2\nEffective: 1 November 2004\nRepublication date: 1 November 2004\nRegulation not amended\n(republication includes editorial amendments\nunder Legislation Act)\nAuthorised by the ACT Parliamentary Counsel\n\nAuthorised by the ACT Parliamentary Counsel—also accessible at www.legislation.act.gov.au\nAbout this republication\nThe republished law\nThis is a republication of the Supervised Injecting Place Trial Regulation 2003, made under the\nSupervised Injecting Place Trial Act 1999 (including any amendment made under\nthe Legislation Act 2001, part 11.3 (Editorial changes)) as in force on 1 November 2004. It also\nincludes any commencement, repeal or expiry affecting the republished law.\nThe legislation history and amendment history of the republished law are set out in endnotes 3\nand 4.\nKinds of republications\nThe Parliamentary Counsel’s Office prepares 2 kinds of republications of ACT laws (see the\nACT legislation register at www.legislation.act.gov.au):\n authorised republications to which the Legislation Act 2001 applies\n unauthorised republications.\nThe status of this republication appears on the bottom of each page.\nEditorial amendments\nThe Legislation Act 2001, part 11.3 authorises the Parliamentary Counsel to make editorial\namendments and other changes of a formal nature when preparing a law for republication.\nEditorial changes do not change the effect of the law, but have effect as if they had been made\nby an Act commencing on the republication date (see Legislation Act 2001, s 115 and s 117).\nThe changes are made if the Parliamentary Counsel considers they are desirable to bring the law\ninto line, or more closely into line, with current legislative drafting practice.\nThis republication includes amendments made under part 11.3 (see endnote 1).\nUncommenced provisions and amendments\nIf a provision of the republished law has not commenced or is affected by an uncommenced\namendment, the symbol U appears immediately before the provision heading. The text of the\nuncommenced provision or amendment appears only in the last endnote.\nModifications\nIf a provision of the republished law is affected by a current modification, the\nsymbol M appears immediately before the provision heading. The text of the modifying\nprovision appears in the endnotes. For the legal status of modifications, see Legislation Act\n2001, section 95.\nPenalties\nThe value of a penalty unit for an offence against this republished law at the republication date\nis—\n(a) if the person charged is an individual—$100; or\n(b) if the person charged is a corporation—$500.\n\nR2\n01/11/04\nSupervised Injecting Place Trial Regulation 2003\nEffective: 01/11/04\ncontents 1\nAuthorised by the ACT Parliamentary Counsel—also accessible at www.legislation.act.gov.au\nAustralian Capital Territory\nSupervised Injecting Place Trial\nRegulation 2003\nmade under the\nSupervised Injecting Place Trial Act 1999\nContents\nPage\n1 Name of regulation 2\n3 Reduction of membership of advisory committee—Act, s 20 (2) 2\n4 Extension of membership of advisory committee—Act, s 20 (2) 2\nEndnotes\n1 About the endnotes 3\n2 Abbreviation key 3\n3 Legislation history 4\n\nContents\nPage\ncontents 2 Supervised Injecting Place Trial Regulation 2003\nEffective: 01/11/04\nR2\n01/11/04\nAuthorised by the ACT Parliamentary Counsel—also accessible at www.legislation.act.gov.au\n4 Amendment history 4\n5 Earlier republications 4\n\nR2\n01/11/04\nSupervised Injecting Place Trial Regulation 2003\nEffective: 01/11/04\npage 1\nAuthorised by the ACT Parliamentary Counsel—also accessible at www.legislation.act.gov.au\nAustralian Capital Territory\nSupervised Injecting Place Trial\nRegulation 2003\nmade under the\nSupervised Injecting Place Trial Act 1999\n\nSection 1\npage 2 Supervised Injecting Place Trial Regulation 2003\nEffective: 01/11/04\nR2\n01/11/04\nAuthorised by the ACT Parliamentary Counsel—also accessible at www.legislation.act.gov.au\n1 Name of regulation\nThis regulation is the Supervised Injecting Place Trial Regulation\n2003.\n3 Reduction of membership of advisory committee—Act,\ns 20 (2)\nThe membership of the advisory committee is reduced by omitting\nprovision for the membership of people nominated by and\nrepresenting the National Centre for Epidemiology and Health, the\nCanberra Injectors Network and the Australian Intravenous League.\n4 Extension of membership of advisory committee—Act,\ns 20 (2)\nThe membership of the advisory committee is extended by including\nthe following:\n(a) 1 person nominated by and representing the National Centre\nfor Epidemiology and Population Health;\n(b) 2 people nominated by and representing the Australian\nInjecting and Illicit Drug Users League, of whom 1 must be an\nACT-based peer representative.\n\nEndnotes\nAbout the endnotes 1\nR2\n01/11/04\nSupervised Injecting Place Trial Regulation 2003\nEffective: 01/11/04\npage 3\nAuthorised by the ACT Parliamentary Counsel—also accessible at www.legislation.act.gov.au\nEndnotes\n1 About the endnotes\nAmending and modifying laws are annotated in the legislation history and the\namendment history. Current modifications are not included in the republished\nlaw but are set out in the endnotes.\nNot all editorial amendments made under the Legislation Act 2001, part 11.3 are\nannotated in the amendment history. Full details of any amendments can be\nobtained from the Parliamentary Counsel’s Office.\nUncommenced amending laws and expiries are listed in the legislation history and\nthe amendment history. These details are underlined. Uncommenced provisions\nand amendments are not included in the republished law but are set out in the last\nendnote.\nIf all the provisions of the law have been renumbered, a table of renumbered\nprovisions gives details of previous and current numbering.\nThe endnotes also include a table of earlier republications.\n2 Abbreviation key\nam = amended ord = ordinance\namdt = amendment orig = original\nch = chapter par = paragraph/subparagraph\ndef = definition pres = present\ndict = dictionary prev = previous\ndisallowed = disallowed by the Legislative (prev...) = previously\nAssembly pt = part\ndiv = division r = rule/subrule\nexp = expires/expired renum = renumbered\nGaz = gazette reloc = relocated\nhdg = heading R[X] = Republication No\nIA = Interpretation Act 1967 RI = reissue\nins = inserted/added s = section/subsection\nLA = Legislation Act 2001 sch = schedule\nLR = legislation register sdiv = subdivision\nLRA = Legislation (Republication) Act 1996 sub = substituted\nmod = modified/modification SL = Subordinate Law\no = order underlining = whole or part not commenced\nom = omitted/repealed or to be expired\n\nEndnotes\n3 Legislation history\npage 4 Supervised Injecting Place Trial Regulation 2003\nEffective: 01/11/04\nR2\n01/11/04\nAuthorised by the ACT Parliamentary Counsel—also accessible at www.legislation.act.gov.au\n3 Legislation history\nThis regulation was originally the Supervised Injecting Place Trial Regulations\n2003. It was renamed under the Legislation Act 2001.\nSupervised Injecting Place Trial Regulation 2003 SL2003-24\nnotified LR 31 July 2003\ns 1, s 2 commenced 31 July 2003 (LA s 75 (1))\nremainder commenced 1 August 2003 (s 2)\n4 Amendment history\nName of regulation\ns 1 am R2 LA\nCommencement\ns 2 om LA s 89 (4)\n5 Earlier republications\nSome earlier republications were not numbered. The number in column 1 refers to\nthe publication order.\nSince 12 September 2001 every authorised republication has been published in\nelectronic pdf format on the ACT legislation register. A selection of authorised\nrepublications have also been published in printed format. These republications\nare marked with an asterisk (*) in column 1. Except for the footer, electronic and\nprinted versions of an authorised republication are identical.\nRepublication\nNo and date\nEffective Last\namendment\nmade by\nRepublication\nfor\nR1\n1 Aug 2003\n1 Aug 2003–\n31 Oct 2004\nnot amended new regulation\n\n© Australian Capital Territory 2004","sortOrder":0}],"analysis":{"flash_summary_failed":{"failed":true,"reason":"Unauthenticated. Configure AI_GATEWAY_API_KEY or use a provider module. Learn more: https://ai-sdk.dev/unauthenticated-ai-gateway","source":"analysis-cron"},"flash_summary":{"complexity_score":2,"scope_assessment":{"changed":true,"description":"The regulation alters the advisory committee's composition: it omits provision for nominees from the National Centre for Epidemiology and Health, the Canberra Injectors Network and the Australian Intravenous League (s 3), and adds nominees from the National Centre for Epidemiology and Population Health (1 person) and the Australian Injecting and Illicit Drug Users League (2 people, one ACT-based peer) (s 4). This shifts which organisations formally provide advice to the trial and modifies representative requirements."},"complexity_factors":["Very short instrument: only two operative provisions (ss 3–4) making targeted changes to advisory committee membership.","Cross-reference to primary Act (s 20(2)) — requires reading the Act to see the broader appointment framework and legal effect.","Specific nomination conditions introduced (s 4(b): 1 must be an ACT-based peer) which create a modest eligibility/representation requirement.","Administrative/compliance burden concentrated on the named organisations to nominate representatives (s 3–4).","Minor textual inconsistency in naming: s 3 refers to 'National Centre for Epidemiology and Health' while s 4 uses 'National Centre for Epidemiology and Population Health' — potential ambiguity for implementers.","Document includes editorial/republishing material and penalty-unit information in the preface, which can distract from the core substantive change."],"plain_english_summary":"This regulation changes who sits on the advisory committee for the Supervised Injecting Place Trial. It removes nomination slots for three named groups and creates new slots: one nominee from the National Centre for Epidemiology and Population Health and two from the Australian Injecting and Illicit Drug Users League (one must be an ACT-based peer). It affects the committee and the named organisations required to provide nominees, and therefore alters who formally advises the trial."},"kimi_summary":{"content_quality":"ok","complexity_score":2,"scope_assessment":{"changed":false,"description":"The regulation remains tightly scoped to its original purpose: adjusting advisory committee membership under the parent Act. There is no expansion beyond this narrow administrative function."},"complexity_factors":["Extremely short—only 2 substantive sections (sections 3 and 4)","No defined terms section; relies entirely on definitions in the parent Act","No cross-references to other legislation except the enabling Act (Supervised Injecting Place Trial Act 1999)","Simple, direct operative provisions without conditional logic or exceptions","No penalty provisions, enforcement mechanisms, or procedural requirements","Essentially a membership list amendment with no substantive policy complexity"],"plain_english_summary":"This regulation updates who has guaranteed seats on the advisory committee for the ACT supervised injecting facility trial, removing three previously named organisations and replacing them with representatives reflecting an organisational name change and continued peer representation—including one member based in the ACT.\n\nIt affects committee members, the organisations losing or gaining representation, and service users, by reshaping which community and health voices formally advise the trial’s operation."},"issue_detection":{"absurdities":[],"contradictions":[]}},"importantCases":[],"_links":{"self":"/api/acts/supervised-injecting-place-trial-regulation-2003","history":"/api/acts/supervised-injecting-place-trial-regulation-2003/history","analysis":"/api/acts/supervised-injecting-place-trial-regulation-2003/analysis","conflicts":"/api/acts/supervised-injecting-place-trial-regulation-2003/conflicts","importantCases":"/api/acts/supervised-injecting-place-trial-regulation-2003/important-cases","documents":"/api/acts/supervised-injecting-place-trial-regulation-2003/documents"}}